Early Labs

Early LabsEarly Labs
Early Labs

Early Labs

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Website
DR 1.62017Active7Tel Aviv, Israel
Rate
Advertise here

About

Early Labs is developing a novel, proprietary multi-cancer screening platform that utilizes Volatile Organic Compound (VOC) biomarkers for early cancer detection. Their Biosensor Platform (BSP) Urine Test aims to make cancer screening accurate, accessible, affordable, and acceptable for patients, payers, policymakers, and providers. This non-invasive, self-administered test seeks to increase survival rates and improve quality of life by identifying cancer at its earliest stages.
Frequently asked

What does Early Labs do?

Early Labs is developing a novel, proprietary multi-cancer screening platform that utilizes Volatile Organic Compound (VOC) biomarkers for early cancer detection. Their Biosensor Platform (BSP) Urine Test aims to make cancer screening accurate, accessible, affordable, and acceptable for patients, payers, policymakers, and providers. This non-invasive, self-administered test seeks to increase survival rates and improve quality of life by identifying cancer at its earliest stages.

What is Early Labs's revenue?

StartupHub estimates Early Labs's annual revenue at $1.3M (range $687K to $1.8M, 66% confidence), based on comparable companies in the sector.

Where is Early Labs headquartered?

Early Labs is headquartered in Tel Aviv, Israel.

When was Early Labs founded?

Early Labs was founded in 2017.

What industry does Early Labs operate in?

Early Labs operates in Healthcare, Oncology, Detection, Urine, Diagnostics, HealthTech.

How many employees does Early Labs have?

Early Labs has approximately 7 people on record.

HEADCOUNT
7
DOMAIN RATING
1.6
Comments

No comments yet. Be the first to share your take.